Healthpeak Properties (DOC) Price Target Revised by Wells Fargo | DOC Stock News

Author's Avatar
Jun 02, 2025
Article's Main Image

On June 2, 2025, Wells Fargo analyst Connor Siversky maintained an "Equal-Weight" rating on Healthpeak Properties (DOC, Financial). This decision was made as Wells Fargo adjusted its price target for the stock from $22.00 to $20.00.

The revised price target represents a 9.09% decrease from the prior target. The adjustment reflects recent evaluations and aligns with the current market conditions as perceived by Wells Fargo.

Healthpeak Properties (DOC, Financial) continues to trade on the New York Stock Exchange, with the updated price target being a reflection of Wells Fargo's ongoing analysis and market outlook for the company.

Wall Street Analysts Forecast

1929578115860951040.png

Based on the one-year price targets offered by 13 analysts, the average target price for Healthpeak Properties Inc (DOC, Financial) is $21.85 with a high estimate of $26.00 and a low estimate of $18.00. The average target implies an upside of 25.91% from the current price of $17.35. More detailed estimate data can be found on the Healthpeak Properties Inc (DOC) Forecast page.

Based on the consensus recommendation from 17 brokerage firms, Healthpeak Properties Inc's (DOC, Financial) average brokerage recommendation is currently 2.2, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.

Based on GuruFocus estimates, the estimated GF Value for Healthpeak Properties Inc (DOC, Financial) in one year is $21.67, suggesting a upside of 24.9% from the current price of $17.35. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Healthpeak Properties Inc (DOC) Summary page.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.